Histology-Stratified Tumor Control and Patient Survival After Stereotactic Radiosurgery for Pineal Region Tumors: A Report From the International Gamma Knife Research Foundation
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, multicentrická studie
PubMed
28751141
DOI
10.1016/j.wneu.2017.07.097
PII: S1878-8750(17)31197-X
Knihovny.cz E-zdroje
- Klíčová slova
- Gamma knife radiosurgery, Pineal region tumors, Survival, Tumor control,
- MeSH
- dítě MeSH
- dospělí MeSH
- epifýza mozková patologie chirurgie MeSH
- internacionalita * MeSH
- kohortové studie MeSH
- lidé středního věku MeSH
- lidé MeSH
- lokální recidiva nádoru mortalita patologie chirurgie MeSH
- míra přežití trendy MeSH
- mladiství MeSH
- mladý dospělý MeSH
- nádory mozku mortalita patologie chirurgie MeSH
- následné studie MeSH
- pinealom mortalita patologie chirurgie MeSH
- předškolní dítě MeSH
- radiochirurgie mortalita trendy MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- výzkumná zpráva MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
BACKGROUND: Pineal region tumors represent a rare and histologically diverse group of lesions. Few studies are available to guide management and the outcomes after stereotactic radiosurgery (SRS). METHODS: Patients who underwent SRS for a pineal region tumor and for whom at least 6 months of imaging follow-up was available were retrospectively assessed in 5 centers. Data were collected from the medical record and histology level analyses were performed, including actuarial tumor control and survival analyses. RESULTS: A total of 70 patients were treated between 1989 and 2014 with a median follow-up of 47 months. Diagnoses were pineocytoma (37%), pineoblastoma (19%), pineal parenchymal tumor of intermediate differentiation (10%), papillary tumor of the pineal region (9%), germinoma (7%), teratoma (3%), embryonal carcinoma (1%), and unknown (14%). Median prescription dose was 15 Gy at the 50% isodose line. Actuarial local control and survival rates were 81% and 76% at 20 years for pineocytoma, 50% and 56% at 5 years for pineal parenchymal tumor of intermediate differentiation, 27% and 48% at 5 years for pineoblastoma, 33% and 100% at 5 years for papillary tumor of the pineal region, 80% and 80% at 20 years for germinoma, and 61% and 67% at 5 years for tumors of unknown histology. New focal neurological deficit, Parinaud syndrome, and hydrocephalus occurred in 9%, 7%, and 3% of cases, respectively. CONCLUSIONS: SRS is a safe modality for the management of pineal region tumors. Its specific role is highly dependent on tumor histology. As such, all efforts should be made to obtain a reliable histologic diagnosis.
Department of Neurological Surgery University of Virginia Charlottesville Virginia USA
Na Homolce Hospital Prague Czech Republic
Taipei Veterans General Hospital Neurological Institute Taipei Taiwan
Citace poskytuje Crossref.org